secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2026-03-16T23:59:59+00:00
Accession:  0001193125-26-108439
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics to suspend trading on Nasdaq March 17 after delisting appeal withdrawal
--------------------------------------------------------------------------------

- Company withdrew appeal of February 2, 2026 Nasdaq delisting determination.
- Nasdaq confirmed suspension of common stock trading at open on March 17, 2026.
- Nasdaq will file Form 25 with SEC after internal procedural periods elapse.
- No trading halt or additional compliance period cited; delisting is final.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000119312526108439/0001193125-26-108439-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000119312526108439/d55950d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-108439

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer